Division of Infectious Diseases Clinical Fellows

Eran Bendavid

Alicia Chang

Aarthi Chary

Birgitt Dau

Shirit Einav

Philip Grant

Anita Koshy

Philip Pang

Cybèle Renault

Frank Trinh

Stephanie Barrett Troy

Eran Bendavid

Eran Bendavid, completing his 2 nd year as a Clinical Fellow, is a native of Israel. He received his MD degree from Harvard Medical School, and completed his residency at the University of Pennsylvania and at Stanford.

His research interests include: Utilizing methods from several disciplines -- political science, economics and epidemiology -- to study the prevention and treatment of infectious diseases in developing countries. His current projects are focused on modeling cost effectiveness of increasing the use of CD4 counts in resource poor setting; the relationship of governance to health care delivery; the behavioral effects of increased HAART availability; and the design of affordable genotyping techniques for resource-poor regions.

Among his mentors are Drs. Doug Owens, Dennis Israelski, David Katzenstein, and Bob Shafer.

List of publications:

1. Weissman JS, Rothschild J, Bendavid E, Cook, EF, Sprivulis P, David-Kasdan J, Bender M, Evans S, Haug P, Lloyd J, Selbovitz LG, Murff H, Bates DW. Hospital Workload and Adverse Events. Accepted, Medical Care.

2. Bendavid E, Kaganova J, Needleman J, Gruenberg L, Weissman JS. Complication Rates on Weekends and Weekdays in U.S. Hospitals. Accepted, American Journal of Medicine.

3. Campbell EG, Vogeli C, Yucel R, Bendavid E, Jones LM, Anderson LA, Louis KS. Data Withholding and the Next Generation Scientists: Results of a National Survey. Academic Medicine. 81(2): 128-136, 2006.

4. Weissman, JS, Bendavid E. Should U.S. Hospitals Go 24/7? American Journal of Medicine. 117(3): 202-203, 2004.

5. Campbell EG, Bendavid E. Data-sharing and data-withholding in genetics and the life sciences: results of a national survey of technology transfer officers. Journal of Health Care Law & Policy. 6(2):241-55, 2003.

Back to Top

Alicia Chang

Alicia Chang received her MD degree from UCSF, and completed her residency in Internal Medicine at Brigham and Women’s Hospital in Boston. Currently in her 4 th year at Stanford, she is completing the MS degree in Epidemiology under the mentorship of Dr. Julie Parsonnet. Dr. Chang’s research interests include understanding the effects of chronic disease on host susceptibility to infections, principally to M. tuberculosis. Her current projects include a clinical study to evaluate the effect of diabetes on risk of active TB, a collaboration with the Santa Clara County TB clinic to study the effect of lengthening isoniazid therapy for latent TB infection, and a clinical challenge study to evaluate the effect of H. pylori and hypochlorhydria on subsequent infection with enteropathogenic E. coli.

Back to Top

Aarthi Chary

Aarthi Chary, MD is a 1st year fellow originally from Ohio, where she  completed medical school at Case Western Reserve University. More recently she has called Oregon home, after completing her internal medicine training at Oregon Health Sciences University and spending an interim year working as both a teaching hospitalist and a research assistant in a tuberculosis lab. Her research interests are focused primarily on clinical HIV, public health and epidemiology.

Back to Top

Birgitt Dau

Birgitt L. Dau, MD, is a 2nd year ID fellow.  She completed her medical
school training at the University of Chicago Pritzker School of Medicine.
Her residency training was at the University of Washington in Seattle.  Her
research is focused on looking at mutational patterns in HIV and how they
are associated with clinical outcomes for HIV-infected patients.  Currently
she is analysing the connection domain of HIV reverse transciptase in a
population of highly treatment-experienced patients.  She is looking at what
antiretroviral treatment history is associated with developing these
mutations, and what impact these mutations have on response to future
antiretroviral therapy.

Mentor: Mark Holodniy, MD

Back to Top

Shirit Enav

Shirit Einav, MD, 3rd year ID fellow. She completed her medical school training at the Sackler school of medicine in Tel-Aviv university, Israel. She did her residency in Internal Medicine at Beth Israel Deaconess Medical Center, Harvard University, Boston. Her research interest is molecular virology of Hepatitis C virus. More specifically, she is interested in identifying new viral targets for potential novel anti-HCV specific treatment. She is also interested in viral-host interactions and in viral-induced oncogenesis.

Mentor: Dr. Jeffrey Glenn (GI)

Included among her ongoing projects: translating her recently identified target of NS4B GTpase domain to the development of a novel anti-HCV strategy, identifying new viral-host protein-protein interactions by a novel methodology, identifying novel mechanisms for viral related hepatocarcinogenesis and more.

List of publications:

• Chou S, Einav S, and Shafer RW (2007). Mechanisms of resistance to antiviral agents. In Manual of clinical microbiology, 9th edition, Murray PR ed, Baron EJ ed, Jorgensen JH ed, Pfaller MA ed, Tenover FC ed, and Yolken RH ed. Americal Society of Microbiology, In press.

• Einav S, Elazar M, Danieli T, and Glenn JS. A nucleotide binding motif in HCV NS4B mediates HCV RNA replication. Journal of virology. 2004 Oct 78 (20):11288-95.

• Einav S, Glenn JS. Prenylation inhibitors: a novel class of antiviral agents. J antimicrob chemo. 2003 November; 52: 883-886. Review.

• Einav S, Koziel MJ. Immunopathogenesis of Hepatitis C in the Immunosuppressed host. Transpl Infect Dis. 2002 June; 4(2):85-92. Review.

• Einav S, Pozdnyakova OO, Ma M, Carroll MC. Complement C4 is protective for lupus disease independent of C3. Journal of Immunology. 2002 Feb1;168(3):1036-41.

Back to Top

Philip Grant

Phil Grant, MD, is a 1st year fellow originally from Pasadena, California. He completed his medical school at UCSF and residency at University of Washington. His research interests are focused on clinical HIV.

Back to Top

Anita Koshy

Anita Koshy, MD (2 nd year) originally hails from the great state of New Mexico. She attended medical school at Duke University, where she was voted least likely to ever recross the Mason-Dixon Line. She began her training in Internal Medicine at University of Washington in Seattle, WA. After a scant two years, she decided Internal Medicine residency was too short and changed to Neurology residency at the University of California, San Francisco. After completing her Neurology residency, she decided to further extend her housestaff years by becoming an Infectious Disease fellow, with the goal of ultimately settling in the small but burgeoning field of neuro-infectious disease. Her research interests are in the immunology and pathogenesis of central nervous system infections. To that end, she will be working with John Boothroyd, PhD who studies Toxoplasmosis gondiiin vitro as well as in a murine model. Her specific fellowship projects have not been defined at this time, as she is currently on maternity leave.

Mentor: John Boothroyd, PhD

Publications:

Chiu, CY, Rouskin S, Koshy A, Urisman A, Fischer K, Yagi S, Schnurr D, Eckburg PB, Tompkins LS, Blackburn BG, Ganem D, DeRisi JC. Microarray detection of human parainfluenzavirus 4 infection associated with respiratory failure in an immunocompetent adult. CID 2006; 43 (8): e71-e76.

Jiang X, Mu D, Manabal C, Koshy AA, Christen S, Tauber MG, Vexler ZS, Ferriero D. Differential vulnerability of immature murine neurons to oxygen-glucose deprivation. Exp Neurology 2004; 190(1): 224-32.

Almli LA, Hamrick SE, Koshy AA, Tauber MG, Ferriero DM. Multiple pathways of neuroprotection against oxidative stress and excitotoxic injury in the immature primary hippocampal neurons. Dev Brain Research 2001; 132: 121-129.

Koshy AA, Almli LM, Tauber M, Ferriero DM. Immature hippocampal neurons in vitro show increased susceptibility to reactive oxygen species. Society for Neurosci Abst 1998; 24:805.

Back to Top

Philip Pang

Phillip S. Pang, M.D., Ph.D., went to Stanford University for his undergraduate degree in biological sciences.  He completed the MST program at Columbia University in 2004, and returned to Stanford for his residency in Internal Medicine.  He is currently fast tracking in the Infectious Disease Fellowship here at Stanford.  His Ph.D. thesis primarily focused on RNA protein interactions, specifically the NS3 helicase from hepatitis C and it's molecular properties.  A second part of his Ph.D. work focused on designing new statistical techniques to analyze related genomes in an effort to extract functional information: in silico molecular analysis. International and domestic patents on the SHEVEK method which resulted from his work are currently pending.  His current interests are exploring through both wet lab and dry lab techniques the immunology and pathogenesis of viruses.

Back to Top

Cybèle Renault

Back to Top

Frank Trinh

Back to Top

Stephanie Barrett Troy

Back to Top